Wanda Information (300168): Won the bid for the procurement project of Shanghai Municipal Pharmaceutical Centralized Bidding and Procurement Affairs Management Office (Shanghai Pharmaceutical Procurement Center), with a bid amount of 2.506 million yuan.

NightAirdropper · 2026-03-25T13:19:17+00:00

Wanda Information Co., Ltd. was awarded the procurement project by the Shanghai Municipal Medical Insurance Center, with a contract amount of 2.506 million yuan. In 2024, the company's operating revenue was 2.011 billion yuan, a decrease of 18.19% year-on-year, with a net loss of 686 million yuan. In the first half of 2025, the operating revenue was 933 million yuan, with a net loss of 299 million yuan, indicating some improvement in business performance.

NightAirdropper

2026-03-25 13:19:17

Abstract generation in progress

According to Tongbi Finance, Qichacha data shows that, based on the “Shanghai Medical Insurance and Pharmaceutical Procurement Intelligent Review Management Subsystem Bid (Winning) Results Announcement,” Wanda Information Co., Ltd. announced winning the Shanghai Medical Procurement Center’s centralized pharmaceutical bidding and procurement project on March 24, 2026, with a bid amount of 2.506 million yuan.

Related listed company: Wanda Information (300168.SZ)

Tongbi Finance Tips:

Wanda Information (300168.SZ) reported a revenue of 2.011 billion yuan in 2024, with a revenue growth rate of -18.19%. The net profit attributable to the parent company was -686 million yuan, with a net profit growth rate of 23.70%. The return on equity was -34.56%.

In the first half of 2025, the company’s revenue was 933 million yuan, with a growth rate of 1.09%. The net profit attributable to the parent company was -299 million yuan, with a growth rate of 18.20%.

The company currently belongs to the information technology industry, mainly producing industry-specific software. In 2024, the main business composition was: software development 48.23%; operation services 31.16%; system integration 20.6%.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.